PMCPA’s 2026 Social Media Guidance: Compliance Priorities Companies Should Address Now
Key Takeaways The PMCPA’s 2026 Social Media Guidance reflects the increasing role of digital channels in pharmaceutical communications. Companies are
Blog
Right-Sized Compliance Support: Meeting the Needs of Both Emerging Biotech and Global Pharma
Key Takeaways Compliance programs should reflect the size, maturity, and operational complexity of an organisation. Emerging biotech companies benefit most
AI in Healthcare Compliance: Navigating Opportunities, Risks, and Regulatory Landscapes
Artificial Intelligence (AI) is revolutionising healthcare compliance by enhancing efficiency, accuracy, and proactive risk management. Healthcare compliance officers are increasingly
Navigating Country-Level Accountability in Europe: A Key Pillar of Healthcare Compliance
At Eunomia Pharma Services, we guide pharmaceutical companies through Europe’s complex regulatory landscape. As firms expand across markets, establishing clear
Scalable Compliance Models for Growing Pharma in the Age of AI
As pharmaceutical companies scale in today’s AI-driven environment, one foundational element often lags behind: compliance infrastructure. For emerging biotechs and
Entering Phase III? Compliance Expectations Already Have
Many biotech companies treat healthcare compliance as something to “scale later.” In reality, Phase III is the moment when compliance
From Risk to Resilience: Why Third-Party Risk Management Is Pharma’s Biggest Competitive Advantage
Pharmaceutical and biotechnology companies rarely expand across borders alone. Distributors, service providers, local agents, logistics partners, and medical engagement vendors
Compliance Gap Analysis: Reducing Risk Without Slowing Growth
Regulatory expectations, ethical standards, and stakeholder scrutiny continue to intensify across the healthcare and life sciences landscape. Despite significant investments
Sunshine Act in France: Understanding the Transparency in Healthcare System
Transparency in healthcare has become a cornerstone of compliance and ethical collaboration between pharmaceutical companies and healthcare professionals (HCPs). In
Transparency Reporting in the Pharmaceutical Industry: Legal Compliance Versus Ethical Responsibility
Transparency reporting in the pharmaceutical industry has evolved from a niche compliance requirement into a central pillar of corporate governance
